News Focus
News Focus
icon url

Whalatane

10/16/25 11:38 AM

#137 RE: ErnieBilco #136

Baird analyst Joel Beatty maintains Amylyx Pharmaceuticals (AMLX.NaE) with a Outperform and raises the price target from $10 to $19.



Kiwi